Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer
Oppenheimer raised the firm's price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on the shares. The firm sees the Delaware court's verdict in favor of Acadia as consistent with its expectations for Nuplazid intellectual property protection while removing a perceived overhang on the shares. The court specifically concluded that Acadia demonstrated by preponderance of evidence that Aurobindo infringes patent claims, the analyst tells investors in a research note. Opco now anticipates investor focus to reset back to key dynamics following the Q1 update and ahead of research and development day on June 25.
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACAD:
Disclaimer & DisclosureReport an Issue
Acadia Pharmaceuticals price target raised to $30 from $27 at Needham
ACADIA Pharmaceuticals: Buy Rating Affirmed Amid Legal Victory and Promising R&D Prospects
District court finds Aurobindo infringes Acadia Pharmaceuticals patent claims
Acadia Pharmaceuticals files to sell 43.58M shares of common stock for holders
ACADIA Pharmaceuticals Reports Strong Q1 Earnings Growth
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Why Intel's (INTC) Comeback Might Happen Sooner Than Expected
As an investor who's watched Intel's (INTC) challenges unfold over the past few years, I'm genuinely excited about Lip-Bu Tan stepping in as CEO. Tan's approach is both bold and strategic—the exact combination Intel desperately needs. He's already making aggressive moves to restructure the company, ramp up investments in manufacturing and AI, and put the foundry business at the forefront. Despite the plethora of both internal and external turmoil, INTC stock has managed to post a flat first six months of 2025. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Tan is steering Intel not only to reclaim its former dominance but potentially to exceed it. I'm bullish on the outlook—but realistic, too—knowing it will take time for Intel to solidify its AI foothold and deliver meaningful returns in the years ahead. Since taking the helm as CEO in March 2025, Tan has wasted no time launching a significant restructuring to slash layers of middle management that have long bogged down Intel's innovation and decision-making. The plan calls for reducing the workforce by about 20%—a tough but necessary move to streamline the organization and accelerate its agility. This isn't just about trimming costs; it's about making Intel leaner and faster. The company aims to reduce operating expenses to around $17 billion by FY 2025. While layoffs are never easy, Intel has grown bloated compared to rivals and now faces an intensely competitive market where survival—and success—demand swift action. As things stand, Intel lags behind its sector peers on several key metrics. I'm confident that a leaner Intel will be sharper, faster, and better positioned to innovate boldly and prove its strength to the competition. However, Tan must handle the workforce cuts with care, focusing on retaining key talent and maintaining morale through a strong, principled leadership approach. Arguably, Tan's boldest move is his unwavering commitment to Intel's advanced manufacturing, especially the cutting-edge 18A node (1.8nm) technology. Set to power Intel's Panther Lake CPUs by late 2025, this breakthrough could dramatically boost energy efficiency and performance, potentially allowing Intel to finally compete toe-to-toe with giants like TSMC (TSM) and Samsung (SSNLF). On the foundry front, Intel Foundry Services (IFS) is gaining serious momentum. High-profile deals—most notably with Microsoft (MSFT)—to utilize Intel's 18A process could transform Intel into a fierce contender in the foundry market. Securing a few more marquee contracts from the likes of Nvidia (NVDA) or Apple (AAPL) would be a game-changer, sparking a significant surge in investor confidence and substantially lifting Intel's valuation. That said, delays in the massive Ohio manufacturing facility, now pushed back to around 2030, raise concerns about capacity constraints and potential missed opportunities if chip demand suddenly spikes. Intel's challenge going forward will be striking the right balance in capital allocation and maintaining a nimble leadership team ready to seize emerging market opportunities quickly. Looking ahead to 2028, Intel's financial health will largely depend on how well it executes its strategy. Analysts project relatively flat to slightly declining revenue in FY 2025, hovering between $50 billion and $53 billion, with a modest recovery expected afterward. Earnings per share of around $0.30 for 2025 seem reasonable, given the current margin pressures. In my base-case outlook, Intel modestly rebounds to about $60 billion in revenue by 2028, with earnings per share approaching $3.00. This scenario would support a share price rising to around $40 from today's $20—a steady but unspectacular return over three years, especially with the dividend still cut during the turnaround. However, in a bull-case scenario, if Intel secures major foundry contracts and capitalizes on strong AI-driven demand, earnings per share could reach $5.00 by 2028, pushing shares into the $70 to $90 range. Conversely, if Intel falters in execution, revenue stagnates, and growth stalls, the stock could remain stuck in the $20s with limited upside potential. Intel is facing significant challenges, and execution, especially talent retention and deployment, will be critical. Any delays or yield issues with the 18A node could undermine confidence and push foundry customers toward competitors like TSMC. Additionally, Intel faces intense competition in chip design from Nvidia (NVDA) and AMD (AMD). Still, I believe the opportunities outweigh the risks. Despite dominant rivals, Intel's valuation remains attractively low, with a price-to-sales ratio under 2, compared to TSMC's 8.5, leaving plenty of room for multiple expansion as earnings momentum improves and investor sentiment turns positive. History shows that undervalued companies staging a comeback can deliver compelling investment stories. When it comes to INTC, most of Wall Street is sitting on the fence. Intel carries a consensus Hold rating, backed by two Buys, 25 Holds, and four Sells. INTC's average stock price target is $21.29, suggesting roughly 6.5% upside over the next year. Although this suggests it may be premature to expect significant gains, investors who buy now and hold through the stagnation phase could reap rewards if sentiment improves—truly a case of being better off being early than too late. There's no guarantee Intel will pull off a complete turnaround, but the company is clearly taking bold steps to tackle years of bloat, strategic drift, and technological lag. Still, winning over a competitive market dominated by entrenched giants won't be easy—it will require grit from management, sharp strategic vision, and a bit of luck. That said, for portfolios seeking value-driven upside, a modest stake in Intel could be a worthwhile investment. I'm cautiously optimistic. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Oppenheimer Increases Snowflake (SNOW) PT, Maintains Outperform Rating
Snowflake Inc. (NASDAQ:SNOW) is one of the 10 tech stocks on Wall Street's radar right now. On June 6, Oppenheimer raised Snowflake Inc.'s (NASDAQ:SNOW) price target to $250 from $225, while maintaining an Outperform rating. As the firm revised the company's price target, it pointed toward Snowflake's Summit'25, which took place in the first week of June. Its keynote speakers included some well-known faces, including Sridhar Ramaswamy, Sam Altman, and Sarah Guo. Oppenheimer noted that the event emphasized stronger data lifecycle support, faster product development, and entry into transactional workloads following the Crunchy Data acquisition. Snowflake (NASDAQ:SNOW) announced at the event that it plans to acquire Crunchy Data, a leading open-source Postgres provider, to launch Snowflake Postgres, which is an enterprise-grade PostgreSQL database tailored for AI applications. A software engineer at work, surrounded by a wall of computer monitors connected to a 'Data Cloud' platform. Oppenheimer's data shows that customer feedback revealed rising adoption of Snowflake due to its user-friendly platform. The firm believes the company's broader product range reflects stronger execution and adaptability, which encourages customers to store more data and develop more applications on its platform. Snowflake (NASDAQ:SNOW) offers a cloud-based data platform that helps organizations centralize their data to generate insights, develop data applications, share data products, and apply AI to address business challenges. While we acknowledge the potential of SNOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
3 hours ago
- Yahoo
Oppenheimer Raises Price Target on Cloudflare (NET), Maintains Outperform Rating
Cloudflare, Inc. (NYSE:NET) is one of the 10 tech stocks on Wall Street's radar right now. On June 5, Oppenheimer raised its price target on Cloudflare, Inc. (NYSE:NET) from $165 to $200 and maintained an Outperform rating after discussions with Phil Winslow, the company's VP of Strategic Finance & Investor Relations. The firm grew more optimistic about the company's growth prospects due to strong momentum in SASE (Secure Access Service Edge) security, boosted by Magic WAN adoption and improvements in CASB (Cloud Access Security Broker) and data loss prevention security features. The firm noted that the Worker platform's expanding capabilities have gained more traction among developers who favor the shift-left approach. Additionally, new AI-focused edge computing technologies like MCP and A2A, along with a new container service for AI workloads, are also some of the reasons for Oppenheimer's positive outlook. The firm is confident that Cloudflare (NYSE:NET) will exceed expectations for 2025, accelerate revenue growth beyond 30%, and reach a $5 billion ARR by the end of 2028. A close-up of a server array powering a cloud-services system. Cloudflare (NYSE:NET) provides a broad suite of cloud-based security, performance, and network services designed to protect and optimize applications, websites, and data across platforms, including SaaS, IoT, and cloud environments. The company offers security solutions including zero trust and DDoS protection, network services such as Magic WAN, and developer tools alongside consumer products like VPN and DNS services. While we acknowledge the potential of NET as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Connectez-vous pour accéder à votre portefeuille
